| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $14.0M | — | +54.0% |
| SG&A Expense | $6.9M | — | +23.6% |
| Operating Income | -$20.9M | — | -42.5% |
| Pre-tax Income | -$19.6M | — | -49.3% |
| Income Tax | $12K | — | +50.0% |
| Net Income | -$19.6M | — | -49.3% |
| EPS (Basic) | -$0.98 | — | +21.6% |
| EPS (Diluted) | -$0.98 | — | +21.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $25.0M | +57.6% | -80.0% |
| Short-term Investments | $57.0M | -30.9% | — |
| Current Assets | $88.8M | -15.6% | -30.0% |
| Total Assets | $99.9M | -14.2% | -27.9% |
| Current Liabilities | $11.6M | -10.4% | +106.6% |
| Total Liabilities | $31.6M | -5.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$17.7M | — | -87.1% |
| Investing Cash Flow | $25.5M | — | — |
| Financing Cash Flow | $1.4M | — | — |
| +98.4% |
| Stockholders' Equity | $68.3M | -17.7% | -44.3% |